Cargando…
Human primed ILCPs support endothelial activation through NF-κB signaling
Innate lymphoid cells (ILCs) represent the most recently identified subset of effector lymphocytes, with key roles in the orchestration of early immune responses. Despite their established involvement in the pathogenesis of many inflammatory disorders, the role of ILCs in cancer remains poorly defin...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
eLife Sciences Publications, Ltd
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7891932/ https://www.ncbi.nlm.nih.gov/pubmed/33554861 http://dx.doi.org/10.7554/eLife.58838 |
_version_ | 1783652792569692160 |
---|---|
author | Vanoni, Giulia Ercolano, Giuseppe Candiani, Simona Rutigliani, Mariangela Lanata, Mariangela Derré, Laurent Marcenaro, Emanuela Schneider, Pascal Romero, Pedro Jandus, Camilla Trabanelli, Sara |
author_facet | Vanoni, Giulia Ercolano, Giuseppe Candiani, Simona Rutigliani, Mariangela Lanata, Mariangela Derré, Laurent Marcenaro, Emanuela Schneider, Pascal Romero, Pedro Jandus, Camilla Trabanelli, Sara |
author_sort | Vanoni, Giulia |
collection | PubMed |
description | Innate lymphoid cells (ILCs) represent the most recently identified subset of effector lymphocytes, with key roles in the orchestration of early immune responses. Despite their established involvement in the pathogenesis of many inflammatory disorders, the role of ILCs in cancer remains poorly defined. Here we assessed whether human ILCs can actively interact with the endothelium to promote tumor growth control, favoring immune cell adhesion. We show that, among all ILC subsets, ILCPs elicited the strongest upregulation of adhesion molecules in endothelial cells (ECs) in vitro, mainly in a contact-dependent manner through the tumor necrosis factor receptor- and RANK-dependent engagement of the NF-κB pathway. Moreover, the ILCP-mediated activation of the ECs resulted to be functional by fostering the adhesion of other innate and adaptive immune cells. Interestingly, pre-exposure of ILCPs to human tumor cell lines strongly impaired this capacity. Hence, the ILCP–EC interaction might represent an attractive target to regulate the immune cell trafficking to tumor sites and, therefore, the establishment of an anti-tumor immune response. |
format | Online Article Text |
id | pubmed-7891932 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | eLife Sciences Publications, Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-78919322021-02-22 Human primed ILCPs support endothelial activation through NF-κB signaling Vanoni, Giulia Ercolano, Giuseppe Candiani, Simona Rutigliani, Mariangela Lanata, Mariangela Derré, Laurent Marcenaro, Emanuela Schneider, Pascal Romero, Pedro Jandus, Camilla Trabanelli, Sara eLife Cancer Biology Innate lymphoid cells (ILCs) represent the most recently identified subset of effector lymphocytes, with key roles in the orchestration of early immune responses. Despite their established involvement in the pathogenesis of many inflammatory disorders, the role of ILCs in cancer remains poorly defined. Here we assessed whether human ILCs can actively interact with the endothelium to promote tumor growth control, favoring immune cell adhesion. We show that, among all ILC subsets, ILCPs elicited the strongest upregulation of adhesion molecules in endothelial cells (ECs) in vitro, mainly in a contact-dependent manner through the tumor necrosis factor receptor- and RANK-dependent engagement of the NF-κB pathway. Moreover, the ILCP-mediated activation of the ECs resulted to be functional by fostering the adhesion of other innate and adaptive immune cells. Interestingly, pre-exposure of ILCPs to human tumor cell lines strongly impaired this capacity. Hence, the ILCP–EC interaction might represent an attractive target to regulate the immune cell trafficking to tumor sites and, therefore, the establishment of an anti-tumor immune response. eLife Sciences Publications, Ltd 2021-02-08 /pmc/articles/PMC7891932/ /pubmed/33554861 http://dx.doi.org/10.7554/eLife.58838 Text en © 2021, Vanoni et al http://creativecommons.org/licenses/by/4.0/ http://creativecommons.org/licenses/by/4.0/This article is distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use and redistribution provided that the original author and source are credited. |
spellingShingle | Cancer Biology Vanoni, Giulia Ercolano, Giuseppe Candiani, Simona Rutigliani, Mariangela Lanata, Mariangela Derré, Laurent Marcenaro, Emanuela Schneider, Pascal Romero, Pedro Jandus, Camilla Trabanelli, Sara Human primed ILCPs support endothelial activation through NF-κB signaling |
title | Human primed ILCPs support endothelial activation through NF-κB signaling |
title_full | Human primed ILCPs support endothelial activation through NF-κB signaling |
title_fullStr | Human primed ILCPs support endothelial activation through NF-κB signaling |
title_full_unstemmed | Human primed ILCPs support endothelial activation through NF-κB signaling |
title_short | Human primed ILCPs support endothelial activation through NF-κB signaling |
title_sort | human primed ilcps support endothelial activation through nf-κb signaling |
topic | Cancer Biology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7891932/ https://www.ncbi.nlm.nih.gov/pubmed/33554861 http://dx.doi.org/10.7554/eLife.58838 |
work_keys_str_mv | AT vanonigiulia humanprimedilcpssupportendothelialactivationthroughnfkbsignaling AT ercolanogiuseppe humanprimedilcpssupportendothelialactivationthroughnfkbsignaling AT candianisimona humanprimedilcpssupportendothelialactivationthroughnfkbsignaling AT rutiglianimariangela humanprimedilcpssupportendothelialactivationthroughnfkbsignaling AT lanatamariangela humanprimedilcpssupportendothelialactivationthroughnfkbsignaling AT derrelaurent humanprimedilcpssupportendothelialactivationthroughnfkbsignaling AT marcenaroemanuela humanprimedilcpssupportendothelialactivationthroughnfkbsignaling AT schneiderpascal humanprimedilcpssupportendothelialactivationthroughnfkbsignaling AT romeropedro humanprimedilcpssupportendothelialactivationthroughnfkbsignaling AT janduscamilla humanprimedilcpssupportendothelialactivationthroughnfkbsignaling AT trabanellisara humanprimedilcpssupportendothelialactivationthroughnfkbsignaling |